Friday, October 30, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 22, 2026

Trump sues ‘woke’ JP Morgan for $5bn over debanking

View original at uk.finance.yahoo.com
Trump sues ‘woke’ JP Morgan for $5bn over debanking Donald Trump is suing JP Morgan and its chief executive, Jamie Dimon. - Krisztian Bocsi/Bloomberg Donald Trump is suing JP Morgan and its chief executive Jamie Dimon for $5bn (£3.7bn) over claims it debanked him…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If anyone would know if there were aliens among us it would be me given satellite array

    80% confidence
  • Argentina's China trade relations not a source of geopolitical conflict with White House

    80% confidence
  • 100 mile x 100 mile solar area enough to power entire US

    80% confidence
  • US will have total access to Greenland with no end and no time limit

    80% confidence
  • Trump's 10% credit card fee cap would be disaster

    80% confidence
  • Limiting factor for AI deployment is fundamentally electrical power

    80% confidence
  • Geopolitical temperature eased a few degrees

    80% confidence
  • Trump lawsuit has no merit

    80% confidence
  • AI growth limited by ability to create energy to power it

    80% confidence
  • Tesla hopes for supervised full self-driving approval in Europe hopefully next month, similar timing for China

    80% confidence
  • Virtually no inflation and extraordinarily high economic growth in US

    80% confidence
  • Trump pulled a predictable U-turn

    80% confidence
  • Trump's attacks on Fed Chairman Jerome Powell threaten inflation

    80% confidence
  • Gulf countries rate Davos because draws different audience than Saudi Davos in Desert or Dubai World Government Summit

    80% confidence
  • Later this year we will be producing more chips than we can turn on

    80% confidence
  • Thanked UK PM Keir Starmer for very strong support during quite a difficult time

    80% confidence
  • US asset sell-off unlikely because US is prettiest house on ugly street

    80% confidence
  • Need to assume life and consciousness extremely rare and might only be us

    80% confidence
  • JP Morgan debanked plaintiffs' accounts because it believed political tide at moment favored doing so

    80% confidence
  • Expects Bank of England rates to move in downward direction

    80% confidence
  • In 5 years AI will be smarter than all of humanity collectively

    80% confidence
  • If European countries sell US debt in response to tariff threats there would be big retaliation on US part because we have all the cards

    80% confidence
  • If there's a big consensual view, take opposite trade position

    80% confidence
  • Solar in space 5x more effective than ground: always sunny, no day-night cycle, no seasonality/weather, 30% more power

    80% confidence
  • Would be very, very surprised if countries sold US assets

    80% confidence
  • JP Morgan needed to distance itself from President Trump and his conservative political views

    80% confidence
  • Stock market went up very substantially after Greenland deal announced

    80% confidence
  • US insurers halving premiums for customers with Tesla software

    80% confidence
  • Hoped we are now in a much better place to focus on Arctic security

    80% confidence
  • Trump's policies are a rupture, old order is dead, heading to world without rules

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com
Trump sues ‘woke’ JP Morgan for $5bn over debanking — Source | Via News | Finance Via News